Search clinical trials for: Beta-3 Receptor Agonist

Total 45611 results

Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

Healthy

France
University Hospital, Strasbourg, France

Recruiting

Dinutuximab Beta at the HUS and the Toulouse Oncopole (DNB)

Neuroblastoma

France
National Cancer Institute (NCI)

Active, not recruiting

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
University of Geneva, Switzerland
University Hospital, Geneva

Recruiting

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring (OPTIMAL TDM)

Efficacy | Toxicity | Beta-lactam Antibiotics | Therapeutic Drug Monitoring | Ceftazidime | Amoxicillin | Meropenem | Imipenem | Piperacillin | Flucloxacillin | Cefepime

Switzerland
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test (CEFAZOPE)

Allergic Reaction | Beta Lactam Adverse Reaction

France
Meir Medical Center

Completed

Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment

Beta-lactam Allergy

Israel
Paul Szabolcs

Recruiting

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Sickle Cell Anemia | Diamond-blackfan Anemia | Beta-thalassemia Major

United States
Ole Frobert, MD, PhD

Recruiting

Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Sweden
University of Aarhus

Recruiting

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

Urinary Incontinence in Children

Denmark
Mansoura University

Recruiting

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

Voiding Disorders

Egypt
National Taiwan University Hospital

Completed

Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes

Overactive Bladder Syndrome

Taiwan
University of California, San Francisco

Completed

Treatment of Incontinence Without Memory Problems (TRIUMPH)

Urge Incontinence | Urinary Incontinence, Urge

United States
Yonsei University

Active, not recruiting

Effect of Mirabegron on Bladder Compliance

Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics

Korea, Republic of
Gregory A. Schmidt

Withdrawn

Beta-blocker Before Extubation

Myocardial Ischemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Recurrent Melanoma | Stage IV Melanoma

United States
Jagiellonian University
University Hospital in Krakow

Not yet recruiting

Beta-blockade in Unruptured Intracranial Aneurysm (BBLURAN)

Intracranial Aneurysm

Poland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
HRH Pharmaceuticals Limited
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaborators

Completed

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

COVID-19

Brazil
Eisai Inc.

Completed

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Insomnia Disorder

United States, Canada, Finland, Germany, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Spain
Velicept Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Overactive Bladder

United States
Unity Health Toronto
Canadian Urological Association

Unknown

Mirabegron And Ureteral Stent-related Pain (MAP) Trial (MAP)

Nephrolithiasis

Canada
Kathmandu University School of Medical Sciences

Completed

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Cervical Cancer | Screening | Stigma

Nepal
Endobar Solutions LLC
Na Homolce Hospital; OB KLINIKA a.s. Pod Krejcárkem 975 Praha 3 - Žižkov Tel... and other collaborators

Completed

The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial (LOSEIT)

Obesity, Morbid

Czechia
LEO Pharma

Completed

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

Psoriasis Vulgaris

France
VANBIERVLIET

Completed

Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS (PICORE)

Pancreatic Tumor | Endoscopic Ultrasonography | Fine Needle Aspiration

France
University of Southern California
Washington University School of Medicine; Keck School of Medicine of USC

Recruiting

Acute Plasma Abeta Responses to Stress

Stress Physiology | Stress Reaction

United States
The University of Hong Kong

Unknown

Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19

COVID-19

China
Velicept Therapeutics, Inc.

Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (VEL-2001)

Overactive Bladder

United States
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Sir Run Run Shaw Hospital

Completed

Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor

Multiple Myeloma

China
Federal Research Institute of Pediatric Hematology...

Unknown

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Anesthesia | Pediatric Cancer | Beta-Thalassemia | Hepatic Metastases | Pediatric Tumor | Pediatric Hepatoblastoma

Russian Federation
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Disorders | Hb-SS Disease | Hemoglobin S | Disease Sickle Cell Anemia | Hemoglobin Beta Thalassemia Disease

United States
Astellas Pharma Inc

Completed

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Urinary Bladder, Overactive

Japan
Donald B. Kohn, M.D.
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

Stem Cell Gene Therapy for Sickle Cell Disease

Sickle Cell Disease

United States
Chulalongkorn University

Not yet recruiting

Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease Patients
Indiana University
IntraMedical Imaging, LLC

Completed

Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions

Prostate Cancer

United States
Virchow Group

Completed

Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect

Intrabony Periodontal Defect

India
University of Roma La Sapienza

Unknown

Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial (HMB)

Sarcopenia | Cirrhosis, Liver

Italy
National Institute of Allergy and Infectious Diseases...

Recruiting

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Malaria | Sickle Cell Disease | Alpha and Beta Thalassemia | Human Physiology

United States
Novartis

Completed

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Beta-Thalassemia | Hemosiderosis

Egypt, Lebanon, Oman, Saudi Arabia, Syrian Arab Republic
Victor Aquino

Available

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Transplant-Related Disorder | GVH - Graft Versus Host Reaction

United States
Hadassah Medical Organization
DIABETES UNIT

Unknown

Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Giving a Vaccination in Three Months
Bioray Laboratories
Xiangya Hospital of Central South University; The 923rd Hospital of Joint Logistics...

Recruiting

Long-term Follow-up Study of BHC001 for TDT

Thalassemia, Beta

China
Nanfang Hospital of Southern Medical University
Shenzhen Second People's Hospital; Shenzhen Children's Hospital; ZhuHai Hospital and other collaborators

Recruiting

Association of Hb F Level With Clinical Severity of Beta Thalassemia

Beta Thalassemia

China
Nanfang Hospital of Southern Medical University
303rd Hospital of the People's Liberation Army; Liuzhou Municipal Maternity... and other collaborators

Recruiting

Genetic Variants Affecting the Clinical Severity of Beta Thalassemia

Beta Thalassemia

China
HaEmek Medical Center, Israel

Completed

Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia

Thalassemia

Israel
Deborah Rund

Completed

Genetic Factors Affecting the Severity of Beta Thalassemia

Beta Thalassemia

Israel
Mahidol University
ChaingMai University

Completed

Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients

Thalassemia

Thailand
National Institute of Diabetes and Digestive and...

Completed

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

Beta Thalassemia

United States
M.D. Anderson Cancer Center

Active, not recruiting

Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia

United States
The University of Texas Medical Branch, Galveston
Shriners Hospitals for Children

Terminated

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

Second or Third Degree Burns

United States

Search clinical trials for: Beta-3 Receptor Agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations